Add to the list of reasons not to have open heart surgery the potential use of Bayer’s (BAY) Trasylol to control bleeding. According to The Wall Street Journal "two studies published in 2006 suggested the drug doubled the risk of kidney failure/" The FDA is reviewing the drug due to the kidney issue and because" two additional studies have suggested the drug also could increase the risk of death."
The FDA has a "black box" warning on the Trasylol label. but the studies do raise that question of why the drug is on the market at all.
Maybe someone should look into this.
Douglas A. McIntyre
Credit card companies are handing out rewards and benefits to win the best customers. A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges. See our top picks for the best credit cards today. You won’t want to miss some of these offers.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
